Get started
Charlotte's Web Holdings, Inc.Charlotte's Web Holdings, Inc.Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Seasonals

6CW trade ideas

LONG $CWBHF Charlottes Web $.16 & $OGI Organigram $2 Don’t overlook this undervalued synergy! British American Tobacco NYSE:BTI already has existing deals with both Charlottes Web Holdings OTC:CWBHF and Organigram Holdings NASDAQ:OGI … There are a few possibilities for how BAT could leverage its partnerships with both companies: Joint Investment: BAT, Charlottes Web, and Organigram could collaborate on a joint venture or even a merger (depending on regulations) to create a larger cannabis and CBD company. This would require significant planning and navigating potential regulatory hurdles.” Market Expansion: BAT global reach could be valuable for both Charlottes Web and Organigram. BAT could help them enter new markets where cannabis or CBD products are legal. For example, BAT might leverage its existing distribution channels for these products. Knowledge Sharing: BAT could act as a bridge between the two companies, facilitating knowledge sharing and best practices in areas like marketing, regulatory compliance, and cultivation techniques.
OTC:CWBHFLong
by CashFlo_Trading
1
#CWEB Target : $3.16 - 4.20 UPTO 71% Charlotte's Web Holdings, Inc. (CWEB), a provider of full spectrum hemp extract products, that saw its stock fall 2.6% and nearer to 52 week lows yesterday, said Thursday it is expanding its retail distribution in California following passage of Assembly Bill 45 (AB 45) on Oct 6. The law formally permits retail sale of products containing hemp-derived cannabidiol (CBD), including dietary supplements, topicals, over-the-counter and pet products. Following AB 45's passage, Charlotte's Web expects California retailers to expand or begin receiving product shipments from the company. Buy @ CAD 1.51 Target : CAD .4.20 Support Level 1 : CAD 4.20 Support Level 2 : CAD 3.16 Resistance 1 : CAD 1. 74 Resistance 2 : CAD 1.35 **Disclaimer - not financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams. I would appreciate your feedback on my analysis. Do not view this idea as a recommendation for trading or investing.
TSX:CWEBLong
by KAPRUKA
2
Canada is to Blame for a Smoked Out Pot Stock MarketHappy 420! When legal recreational cannabis sales began in Canada on Oct 17, 2018, marijuana companies and investors were brimming with confidence... A large industrialized country had finally legalized marijuana. And with an adult population of nearly 30 million people, Canada would finally show the world just how big and lucrative the recreational marijuana industry could be... Aurora Cannabis . Canopy Growth. Aphria. Tilray . They’re all Canadian. And they’re among the biggest marijuana companies in the world... Their stocks were soaring. They were going to take over the world. First Canada. Then the USA. And then the rest of the globe... But what no one had counted on was an inept Canadian bureaucracy... Canada put Health Canada, the countries department of public health, in charge of regulating the Canadian marijuana industry... ...and Health Canada hasn’t been up to the task. Entering 2019, health Canada had more than 800 pending applications for processing, sales, and cultivation licenses. On average, it’s taking 341 days to approve licenses to sell marijuana... And the time it takes to approve cultivation licenses is anywhere from 6 months to a few years. It took Aphria almost 2 years just to get its upgrade of an existing facility approved... The failure to approve retail locations has depressed sales. And the failure to approve grow facilities has made it difficult to keep up with demand... It’s almost as if Health Canada wants the legal marijuana industry to go away... Canada’s marketing and advertising restrictions for marijuana aren’t helping matters either... Canada bans the use of mass advertising, sponsorships, endorsements, testimonials and promotions for Marijuana... It also prohibits communicating information about marijuana’s price or distribution... Canada also artificially restricted the size of the market by allowing only the sale of the flower and oils... These structural flaws have made it difficult for the legal, regulated cannabis industry to take off... In the 3rd quarter of last year the average price (to consumers) of legal marijuana was CA$10.23 per gram, according to Statistics Canada (which is run by the Canadian Government). Statistics Canada reports that the average price of black market marijuana was only CA$5.59... It’s no wonder the big legal marijuana companies in Canada are struggling... Health Canada’s bureaucrat quicksand, combined with its limits on products and marketing, has slowed growth and created a thriving black market... It’s also infected the larger marijuana industry. Every time a Canadian marijuana giant misses earnings or revenue estimates, stock prices for the entire sector plummet. And because pot stocks are dominated by retail investors (institutional investors are largely unable to invest in pot companies because pot is still illegal at the federal level in the US), prices can drop rapidly. Retail investors typically hold on to their investments for less time - and have a lower risk tolerance - than institutional investors... Canada’s approach is fundamentally unacceptable. Fortunately there are sign of progress. Health Canada is trying to speed up the review process for licenses. And the sale of edibles and other cannabis derivatives is expected to begin this month... But it’s going to take some time before the promise of the Canadian market becomes a reality... That doesn’t mean you shouldn’t invest in the big Canadian pot companies. It simply means you have to adjust your timeline for success... Now is a good time to buy because pot stocks are a bargain, especially considering how much the industry is going to grow... Over the course of the next few years, the cannabis market will reach incredible new heights. It won’t happen as quickly as you’d like. It will be a slow and steady March instead of a meteoric rise... But it will happen!!! And that means if you’re going to invest in pot stocks, you have to be in it for the long haul. There’s no shortcut to success. Buy now while you can still get bargain prices. And then hold. You’re investing in what could be a $66 billion global marijuana market by 2025... And these companies, and a few others I’ve picked, represent your best chance to capture a hit from that cone!!! Stay ahead of the masses, Seth Maniscalco Owner, Modern Wealth Management Founder, Crypto Wealth Coach Founder, T.R.A.I.N. #NoMore925 #ProfitsOverPaychecks
OTC:CWBHFLong
by smaniscalco
4
Charlotte's Web Holdings (TSX: CWEB.TO) Dec 12, 2019Currently the entire cannabinoid industry is in a downturn. The sky high valuations that these companies have been commanding past few months have clashed with reality, leaving investors scrambling for cover. The whole premise for the high valuations was the high growth rate. However, as recent events in Canada show, legitimate cannabinoid companies still cannot compete with the black market given the high taxes and the costs of compliance with regulatory requirements. Furthermore, with the government allowing private citizens to grow cannabis, a chunk of the retail market has vanished for these big players. Now the competition among the bigger players is among niche and value added products. Coming to CWEB, it's revenue has grown in the double digits but so has the costs. Currently, the stock commands a PE of 213 (Yahoo Finance), which would theoretically take an investor more than 2 centuries to recoup his/her investment (assuming no growth rate). Critics may point out the impressive rate of growth, but the key question to ask: Is the company generating any money? A quick glance at the Cash Flow statement reveals that although CF was positive from FY17 to FY18; however in the TTM the company has spent 44,000K from its reserves. Furthermore, in the company's short life span, FCF was positive only in 2017. Based on the analysis, CWEB would not find a space in my personal portfolio. It seems that the company is funding it's growth from shareholder equity. In the absence of shareholders pouring in money coupled with a negative FCF, the company would find it challenging to sustain its growth.
TSX:CWEBShort
by advisacorp
Charlotte's Web is the Budweiser of CBD!!Hey Friends! Charlotte’s Web (OTC: CWBHF) is one of the nation’s largest growers of hemp. And it’s laser-focused on the medical uses of cannabis. In fact, Charlotte’s Web was founded from Big Pharma’s failures. Stanley Brothers is the founder of Charlotte’s Web. The company began researching medical cannabis when the Stanley brothers’ uncle developed pancreatic cancer in 2008. Conventional medicine just wasn’t helping. Their research and company came to the forefront when the brothers met Paige Figi. Her daughter Charlotte had Dravet syndrome, a form of epilepsy. Charlotte suffered through up to 300 grand mal seizures a week. By the time she was 5, all the family’s pharmaceutical options had been exhausted. Then she tried a CBD product created by Stanley Brothers. It was created from a special strain of hemp. And it worked. Charlotte’s Web, the CBD product, reduced Charlotte’s seizures to just three per month. It succeeded where Big Pharma had failed. And Stanley Brothers named the product after her. This incredible story spread across the country as the media got a hold of it. Everyone from The Wall Street Journal, Time and The New York Times to NBC and CNN, just to name a few, brought Charlotte’s story to the world. The CNN story from 2013 was especially widely viewed, and I recommend reading it if you haven’t yet. The story helped change America’s mind on the cannabis issue. And through it all, Charlotte’s Web became a powerful brand name and didn’t have to spend a cent on advertising. With the sort of brand recognition it’s cultivating, we could be looking at the Budweiser of cannabis. And in case you’re wondering, Charlotte’s case wasn’t a fluke. Scientists have given Charlotte’s Web a close look. And even in situations where Charlotte’s Web wasn’t a complete fix for epilepsy, it did improve quality of life for patients treated with it. Charlotte’s Web succeeding where Big Pharma failed and they single handedly changed perspectives on medical marijuana… It convinced then-Florida Gov. Rick Scott, a rather conservative politician, to sign his state’s proposed medical marijuana law back in 2014. Charlotte’s Web might be small, but it has staying power. The numbers bear that out. The company has seen rapid growth in revenue. It generated $69.5 million last year. Revenue is projected to grow to $126 million by the end of 2019 and reach $303.5 million in 2020. It’s seen a 73.7% year-over-year revenue growth rate. Charlotte’s Web also has a huge cash reserve relative to its liabilities – $51.4 million to $8.7 million. Between its explosive growth potential and healthy balance sheet, the company’s current sub-$10 share price is a ridiculous steal. I fully expect this company to maintain its spot as the No. 1 brand in CBD and grow into a multibillion-dollar firm over coming years. You don’t have to feel guilty about making money from Charlotte’s Web’s growth. All the money is clean. Cannabis has dozens of medical uses. That means there are dozens of opportunities for companies like Charlotte’s Web to explore. Investing in Charlotte’s Web is a fantastic way to break Murder Inc.’s hold on American medicine while positioning yourself to reap a windfall. The company was recently granted the first patent on a hemp plant in the U.S., which I believe will help cement its brand and lock in future profits. Stay ahead of the masses, Seth Maniscalco
OTC:CWBHFLong
by smaniscalco
1
$cwbhf Expectations low in Charlottes Web HoldingsAverage analysts price target $20.91 | Buy rating. Company profileCharlotte's Web Holdings, Inc. engages in the production and distribution of hemp-based, cannabinoid wellness products. Its products is comprised of tinctures, capsules, topical products, powdered supplements, single-use, beverage, and sport and professional products. The company was founded by Joel Stanley and Jared Stanley in 2013 and is headquartered in Boulder, CO.
OTC:CWBHFLong
by OTCMarketsExpert
Reversal trade in Charlotte's Web HoldingsCannabis stocks may have formed somewhat of a bottom, large to small cap stocks are generally surging today, in what has been a terrible day within the markets. Close watch should be kept on CWBHF for a strong reversal. Company profile Charlotte's Web Holdings, Inc. engages in the production and distribution of hemp-based, cannabinoid wellness products. Its products is comprised of tinctures, capsules, topical products, powdered supplements, single-use, beverage, and sport and professional products. The company was founded by Joel Stanley and Jared Stanley in 2013 and is headquartered in Boulder, CO.
OTC:CWBHFLong
by OTCMarketsExpert